J Korean Soc Pediatr Nephrol.  2006 Oct;10(2):192-200.

Escherichia coli Susceptibility to Antimicrobials in Children with Urinary Tract Infection

Affiliations
  • 1Department of Pediatrics, Seoul Adventist Hospital, Seoul, Korea. jhoon0406@paran.com

Abstract

PURPOSE
This study was performed to identify longitudinal changes in the prevalence of organisms isolated from urinary tract infection(UTI) and in the pattern of Escherichia coli susceptibility to antibiotics during the past 10 years in children with UTI.
METHODS
We performed a retrospective study of a total of 192 urine cultures from children with UTI in the Department of Pediatrics, Seoul Adventist Hospital over two periods(1st: 1995-2000, 2nd:2001-2005). Antimicrobial susceptibility of the isolates was compared between the two groups.
RESULTS
The pathogens of UTI in the two groups were similar. In the first period, E. coli was the leading uropathogen(66.2%) followed by Klebsiella pneumoniae(7.8%), Enterobacter cloacae(6.5%), and others(19.5%). In the second period, E. coli was the leading uropathogen (67%) followed by K. pneumoniae(12.2%), E. cloacae(3.5%), Enterobacter aerogenes(3.5%), and others(13.8%). The susceptibility pattern of E. coli to amoxicillin/clavulanate(87.5%, 81.0 %) did not present any statistically significant difference between the two periods(P>0.05). The susceptibility of E. coli to TMP/SMX(52.4%, 50.0%) was still low with no significant difference between the two periods(P>0.05).
CONCLUSION
Our results suggest that the use of amoxicillin/clavulanate is still an excellent therapeutic option in children with UTI. The low rate of susceptibility to TMP/SMX against uropathogens suggest that TMP/SMX may be reevaluated as the first-line therapeutic drug for UTI.

Keyword

Urinary tract infection; Escherichia coli; Antimicrobial susceptibility

MeSH Terms

Anti-Bacterial Agents
Child*
Enterobacter
Escherichia coli*
Escherichia*
Humans
Klebsiella
Pediatrics
Prevalence
Retrospective Studies
Seoul
Urinary Tract Infections*
Urinary Tract*
Anti-Bacterial Agents
Full Text Links
  • JKSPN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr